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Abstract
Background: Swaziland has one of the highest HIV prevalence rates in sub-Saharan Africa, 26 % of the adult population
is infected with HIV. The prevalence is highest among pregnant women, at 41.1 %. According to Swaziland’s prevention
of mother-to-child transmission (PMTCT) guidelines, approximately 50 % of pregnant women are eligible for antiretroviral
therapy (ART) by CD4 criteria (<350 cells/ml). Studies have shown that most mother-to-child transmission and postnatal
deaths occur among women who are eligible for ART. Therefore, ensuring that ART eligible women are initiated on ART
is critical for PMTCT and for mother and baby survival. This study provides insight into the challenges of lifelong ART
initiation among pregnant women under Option A in Swaziland. We believe that these challenges and lessons learned
from initiating women on lifelong ART under Option A are relevant and important to consider during implementation
of Option B+.
Methods: HIV-positive, treatment-eligible, postpartum women and nurses were recruited within maternal and child
health (MCH) units using convenience and purposive sampling. Participants came from both urban and rural areas.
Focus group discussions (FGDs) and structured interviews using a short answer questionnaire were conducted to gain
an understanding of the challenges experienced when initiating lifelong ART. Seven FGDs (of 5–11 participants) were
conducted, four FGDs with nurses, two FGDs with women who initiated ART, and one FGD with women who did not
initiate ART. A total of 83 interviews were conducted; 50 with women who initiated ART and 33 with women who did
not initiate. Data collection with the women was conducted in the local language of SiSwati and data collection with
the nurses was done in English. FGDs were audio-recorded and simultaneously transcribed and translated into English.
Analysis was conducted using thematic analysis. Transcripts were coded by two researchers in the qualitative software
program MAXqda v.10. Thematic findings were illustrated using verbatim quotes which were selected on the
basis of being representative of a specific theme. The short-answer interview questionnaire included specific
questions about the different steps in the woman’s experience initiating ART; therefore the responses for each
question were analyzed separately.
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Results: Findings from the study highlight women feeling overwhelmed by the lifetime commitment of ART, feeling
“healthy” when asked to initiate ART, preference for short-course prophylaxis and fear of side effects (body changes).
Also, the preference for nurses to determine on an individual basis the number of counseling appointments a woman
needs before initiating ART, more information about HIV and ART needed at the community level, and the need to
educate men about HIV and ART.
Conclusion: Women face a myriad of challenges initiating lifelong ART. Understanding women’s concerns will aid in
developing effective counseling messages, designing appropriate counseling structures, understanding where additional
support is needed in the process of initiating ART, and knowing who to target for community level messages.
Background
In Africa, mother-to-child human immunodeficiency
virus (HIV) transmission (MTCT) is the largest source
of infection in children under 10 years old. Without any
preventive intervention, the risk of MTCT is estimated
to range from 25 to 40 % in low income countries, where
breastfeeding is recommended to HIV-positive women
[1]. Prevention of MTCT requires women to access a se-
quential cascade of services beginning with accessing the
antenatal care clinic (ANC) and testing for HIV. For those
who test HIV positive, additional steps include determin-
ing eligibility for antiretroviral treatment (ART) by per-
forming a CD4 count or applying WHO clinical staging
(prior to universal ART for all pregnant women being rec-
ommended), initiating ART, adhering to ART, accessing
the post-natal care (PNC) services, testing the infant for
HIV and initiating the infant on treatment if necessary [2].
Ensuring that HIV-positive pregnant women receive the
full cascade of PMTCT services is critical to ensuring a
generation free of HIV and acquired immunodeficiency
syndrome (AIDS).
Swaziland’s HIV prevalence rate of 41 % is among the
highest in the world among pregnant women [3]. With
an estimated 34,571 deliveries in 2015, ensuring that
HIV positive pregnant women receive PMTCT services
is critical to reducing the number of HIV-positive
women who transmit the virus to their children [4] and
make progress toward a generation free of HIV.
In 2010, Swaziland began implementing the World
Health Organization (WHO)’s Option A guidelines,
which recommend that HIV-positive women with a CD4
count less than 350 cells/mm or WHO clinical stage III/
IV are offered lifelong ART, while those with CD4 above
350 cells/mm and are stage I/II are offered short-course
prophylaxis. Short-course prophylaxis includes zidovudine
from 14 weeks of pregnancy until labor and delivery; dur-
ing labor women receive single-dose nevirapine with lami-
vudine/zidovudine, continuing the lamivudine/zidovudine
through 7 days postpartum, and infants receive daily
nevirapine until cessation of breastfeeding [5].
In 2013, the WHO guidelines recommended that all
HIV-infected pregnant and lactating women, regardless
of CD4 cell count or clinical status, initiate ART during
pregnancy, which should be continued lifelong (Option B+)
in high prevalence settings such as Swaziland [6]. These
revised guidelines were a significant change from the previ-
ous guidelines, as women with CD4 counts above 350 who
may be asymptomatic and perceive themselves as healthy
are now offered lifelong ART instead of short-course
prophylaxis. In October 2014, Swaziland initiated Option
B+ as the national PMTCT strategy which at the time of
writing is in the process of national roll-out.
The overall acceptance and uptake of lifelong ART
among pregnant and lactating women in Swaziland has
been a challenge. In 2009, only about 50 % of eligible
women were initiated on ART [7]. However, by 2013,
due to intensified client education and improved guide-
lines 72 % of eligible women had initiated ART [8]. Pre-
vious studies have attributed failure or delay of ART
initiation to a variety of factors, including stigma, lack of
disclosure, the need for partner support, food insecurity,
transportation time and cost, negative perceptions of
antiretroviral drugs (ARVs), trust in faith healing and
traditional medicine, cost of treatment, lack of drugs
availability, staff shortages and poor treatment of clients
by health care workers [9–13].
Minimal research has been done, however, to understand
the challenges related to ART initiation among pregnant
women beginning a lifelong commitment to treatment,
whether initiation is for maternal health under Option A
or more broadly for maternal health and prevention of
MTCT under Option B+. This study provides insight into
the challenges of lifelong ART initiation among pregnant
women under Option A in Swaziland. We believe that
these challenges and lessons learned from initiating women
on lifelong ART under Option A are relevant and import-
ant to consider during implementation of Option B+.
Methods
Study sites
The study was conducted in the four regions of Swaziland:
Shiselweni, Lubombo, Hhohho, and Manzini. Study sites
with the highest number of annual deliveries in both urban
and rural locations were purposively selected.
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Study participants
The study participants included nurses and HIV-
positive, postpartum women who were eligible for ART
during their pregnancy under Option A (CD <350 and/
or WHO Stage III/IV disease). The study recruited both
women who did and women who did not initiate ART
during their pregnancy. Nurses who participated in the
study were employed in the maternal and child health
unit for a minimum of 1 year.
Data collection
Data with the HIV-positive, postpartum women were
collected through individual interviews and focus group
discussions (FGDs) in the local language of SiSwati and
FGDs with nurses were conducted in English. The study
originated after review of routine program M&E data by
the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)
which showed that HIV-positive ART-eligible pregnant
women were not initiating ART. The study was designed
to answer the main question of why women were choos-
ing not to initiate ART when they understood that it
would prolong their lives and potentially prevent trans-
mission to their unborn infants. A free listing of potential
reasons was made by the study team and health care pro-
viders were consulted to ensure all critical topic areas
were included. The data collection tools were then drafted
and piloted at non-study sites to ensure that questions
were correctly understood and to estimate the time to
complete the interviews and FGDs.
Short-answer questionnaires were used to conduct in-
dividual interviews with women in the maternity ward
after they had delivered their child and before being
discharged. Since many women do not return for post-
natal care (especially those who did not initiate ART),
interviewing women in the maternity ward provided an
opportunity to interview more women who did not initi-
ate ART. Considering that these women had recently
given birth, the study team did not feel it was appropri-
ate to administer an in-depth interview and instead
opted for a short answer questionnaire which would take
less time to answer the priority research questions. The
short answer questionnaire included a combination of
open- and closed-ended questions to understand women’s
individual trajectories from learning their HIV status to
deciding whether or not to initiate ART, with a focus on
potential barriers to initiation of ART. The closed-ended
questions included yes/no questions, multiple choice and
Likert scale questions. The closed-ended questions were
primarily used to gather demographic data, information
about when women learned their HIV status, if/when they
initiated ART, whether ART was provided at their facility
or they had to be referred and who they consulted before
initiating ART. The Likert question asked on a scale of 1–
5 how difficult it was to initiate ART. The opened ended
questions were used to gather information about messages
they heard at the facility, what information was unclear,
why they decided to initiate or not initiate ART, what
challenges they faced initiating ART and what were the
anticipated challenges with continuing medication and
returning to the facility. Convenience sampling was used
to select participants in the maternity ward. From July to
September 2011 all eligible women at the selected study
sites were invited to participate in the study. Nurses were
trained by the Elizabeth Glaser Pediatric AIDS Foundation
(EGPAF) staff to identify eligible women, obtain written
informed consent, and conduct interviews.
Women who participated in the FGDs were recruited
from the child welfare clinics when they returned for the
child’s immunization visit at 6 or 10 weeks. These time
periods were selected to reduce recall bias and due to
high drop-out rate for the third immunization visit at
14 weeks. Post-delivery is a common drop-off point in
the PMTCT cascade therefore the study sought to gather
the perspectives from multiple time points (immediately
following delivery, 6 and 10 weeks). Convenience sam-
pling was also used to recruit women for the FGDs. Be-
tween January to March 2012 all eligible women who
attended the child welfare clinics at the selected sites
were invited to participate in the FGDs. Nurses were
trained on participant eligibility criteria and referred all
eligible women to onsite RAs who enrolled them in the
study. Those who participated in the FGDs were told a
day and time to return to the facility to participate in
the FGD. The FGD used a semi-structured guide with
open-ended questions to facilitate a discussion about the
barriers and facilitators faced by women when deciding
to initiate ART under Option A. All FGDs were conducted
by EGPAF staff trained in qualitative data collection. All
FGDs had 5–11 participants, were conducted with one
moderator and one note taker, and were audio-recorded.
Purposive sampling was used to recruit nurses for
FGDs between January to March 2012. Nurses were
recruited for FGDs by EGPAF regional PMTCT coor-
dinators in collaboration with the regional clinic su-
pervisors. Given the small number of nurses who
provide services at these facilities, all eligible nurses
providing services in each of the four regions of
Swaziland were invited to participate, and this did not
exceed the maximum number of FGD participants.
The regional coordinator informed the participants
about the time and day the FGD would be conducted.
FGDs with nurses were similarly conducted using a
semi-structured guide with open-ended questions fo-
cused on barriers and facilitators to women initiating
ART, as perceived by nurses. The nurses who partici-
pated in the FGDs were not the same nurses who
interviewed patients, as the FGD participants were re-
cruited from the maternal and child health units, and
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nurses who conducted interviews were based in the
maternity ward.
Prior to implementation all study materials were reviewed
and approved by the Swaziland Scientific and Ethics
Committee. Individuals who participated in the inter-
views provided written informed consent, while FGD
participants provided verbal consent. All efforts were
made to protect participant privacy by limiting collec-
tion of any identifiable information, limiting access of
study data to study staff, and using study ID numbers
instead of names when conducting FGDs.
Data analysis
Audio-recordings of the interviews and FGDs with the
women were transcribed and translated into English
simultaneously. Data were analyzed using thematic ana-
lysis [14]. After transcription, a master list of all findings
was assembled, and codes were determined when a find-
ing was seen to reoccur throughout the data and was
relevant to the research questions. Related codes were
grouped into overarching themes. The codes and themes
were used to create a coding framework. The FGDs were
coded in the qualitative software program MAXqda v.10
by two members of the study team who designed the
study. Thematic findings were illustrated using verbatim
quotes which were selected on the basis of being repre-
sentative of a specific theme.
The short answer questionnaire included specific ques-
tions about the different steps in the woman’s experience
initiating ART; therefore it was more appropriate to analyze
the responses for each question separately. Responses for
each question were compiled and examined for similaries
and differences among the responses and compared to the
FGD data.
Results
A total of 83 individual interviews were conducted; 50
with women who chose to initiate ART and 33 with
women who chose not to initiate ART. Seven FGDs were
carried out with 59 participants; four FGDs with nurses,
two FGDs with women who initiated ART, and one FGD
with women who did not initiate ART. To indicate which
results were more frequently discussed, the results are
presented in the order of least frequently discussed to
most frequently discussed within the two themes. Study
results are highlighted in Table 1.
The majority of women who participated in the inter-
views were between 21 and 30 years of age (Table 2).
Interview participants who did initiate ART were
more commonly single while those who did not initi-
ate ART were more commonly married. The majority
of FGD participants were married. For the FGD par-
ticipants, the most common age was between 26-30.
Across the interviews and FGDs, most women were
Protestant, and the most common educate level was
secondary, except for the FGD participants who did
not initiate ART, whose common education level was
tied between secondary and primary. The majority of
nurses were between the ages of 36-45, employed as
a staff nurse and had been employed for 1-5 years
(Table 3). Detail about nurse designations is provided
in Table 4.
Challenges accepting lifelong ART
The most frequently cited challenges accepting lifelong
ART were feeling “healthy” when asked to initiate ART,
being overwhelmed by the lifetime commitment of drugs,
and preference for short-course prophylaxis.
Feeling “healthy” when asked to initiate ART
Both women and nurses frequently mentioned the be-
lief that ART is for very sick people and that it can be
very difficult for a woman to accept ART when she is
feeling healthy.
Table 1 Key study findings
Challenges accepting lifelong ART
Challenge accepting ART
when feeling “healthy”
• Women struggled with to accept ART
when they felt healthy because ART is
associated with being very ill or having
a low CD4 count.
Preference for short-course
prophylaxis
• Women preferred the short-course
prophylaxis so that they could avoid
disclosure and tell their partner or family




• Most women were familiar with the
concept of developing resistance,
which caused some to delay initiation
until they felt “ready” to commit for life
More information needed on ART
Fear of side effects • The fear of side effects was often
related to deformities and changing
physical appearance. Nurses believed
this was associated with a drug no
longer in use (Stavudine)
Number of clinic
appointments
• Nurses reported considerable variation in
the number of adherence counseling
appointments a woman needed and
advocated for the nurse's discretion to
determine the number of adherence
counseling sessions on an individual basis
More information needed
at the community level
• Nurses reported being too busy at the
facility to provide education sessions in
the community (which had previously
been provided)
Educating men about HIV
and ART
• Women reported their partners lacking
information about HIV and ART and
becoming abusive at the mention of
either topic
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Sometimes you can even ask if the nurses are really
serious or if they are just joking when they tell you that
you are now eligible for HIV medicine when in actual
fact you feel healthy and haven’t fallen sick (Woman).
Nurses discussed the challenge of women believing
that ART is only for the very ill.
Sometime you find that these women come knowing their
HIV status while others come with unknown HIV status.
Those who come up [test] positive, they tend not to go for
ART because they believe ART is for those people, say
those whose CD4 are very low or those who are almost
sick so for them they don’t feel the need to start the ART
because …eh…eh…their coming to the facility is to start
ANC so starting treatment when they are not sick, no
they…they… they don’t feel like [starting ART] (Nurse).
Because these women are feeling healthy and are not
experiencing any symptoms it becomes difficult for them
to justify starting ART.
If for instance, you were to tell me right now that
because I have ‘brackets’ I need to put on casts to
strengthen my legs I won’t agree because I am
comfortable with the way I am. So even with these
women it’s the same thing. I come here healthy to do
my ANC and then all of a sudden you are telling me
I’m sick. I have to be on ART. I think that’s the other
problem. These women come here feeling very healthy
and now they are going back home with a sack of
tablets (Nurse).
Nurses discussed how it’s more challenging for those
who are just learning their HIV status to initiate ART.
Those who are pregnant and have found out about
their HIV positive status during the pregnancy, are
usually the most difficult to initiate. But the one who
fell pregnant knowing her status is generally easier to
initiate. So I think we should strengthen teachings on
HTC and encourage women to make sure that they
know their HIV status before falling because, like I
said it’s easier for those who know their HIV status
than this one (coughs) who has just come and is newly
diagnosed HIV positive (Nurse).
Preference for short course prophylaxis to avoid stigma
The nurses discussed women wanting short course
prophylaxis, especially younger women and those who
Table 2 Demographic characteristics for postpartum women participants














16–20 5 (10 %) 5 (15 %) 0 0
21–25 19 (38 %) 10 (30 %) 5 (31 %) 1 (17 %)
26–30 12 (24 %) 11 (33 %) 5 (31 %) 4 (67 %)
31–35 10 (20 %) 6 (18 %) 5 (31 %) 1 (17 %)
36–40 2 (4 %) 0 1 (6 %) 0
41–44 2 (4 %) 1 (3 %) 0 0
Marital status
Married/living with partner 23 (46 %) 18 (54 %) 11 (69 %) 4 (66 %)
Single 27 (54 %) 15 (45 %) 5 (31 %) 2 (33 %)
Education
None 2 (4 %) 1 (3 %) 0 0
Primary 14 (28 %) 9 (27 %) 5 (31 %) 3 (50 %)
Secondary 31 (62 %) 22 (67 %) 10 (63 %) 3 (50 %)
Tertiary 3 (6 %) 1 (3 %) 1 (6 %) 0
Religion
None 0 2 (6 %) 0 0
Catholic 2 (4 %) 0 2 (13 %) 0
Protestant 39 (78 %) 27 (83 %) 14 (87 %) 6 (100 %)
Islam 0 0 0 0
Other 9 (18 %) 4 (12 %) 0 0
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had been pregnant before and were familiar with the
short course prophylaxis.
I wanted to comment on the issue of those women who
were pregnant before, and were given intrapartum
dose1 and gave birth to a HIV negative baby, and now
on her second pregnancy you tell her that she now has
to initiate ART. Most of these women find this very
hard to take because they do not understand why they
cannot be given the short course instead of the lifetime
commitment. There is a lot of resistance from these
women in most instances, but with on-going counselling
you are able to convince some (Nurse).
Nurses discussed that women prefer the short course
prophylaxis to ART to avoid disclosure to their partner
by claiming the drugs are for the pregnancy.
…some of them say that they haven’t disclosed to their
partners so they say it’s difficult to start ART especially
if you haven’t disclosed your HIV status. They say it’s
better [to take drugs] during the gestation period since
they can just take the drugs as if they are drugs taken
during pregnancy. But then if she gives birth then it’s a
problem because she has to stop taking the drugs since
she has not disclosed to the partner (Nurse).
Women also preferred the prophylaxis because they
were able to receive medication in ANC and avoid
stigma associated with the ART dispensary (when ART
is not available in ANC).
Overwhelmed by lifetime commitment of drugs
Fear of commitment to lifetime therapy was mentioned
frequently by nurses and women.
I was just scared because I had heard them say that
you have to take drugs for life and I was traumatised
that I would have to drink them for the rest of my
life…must I agree to this or not? I just couldn’t believe
it such that I even cried when they told me that I
would have to start taking the medication” (Woman).
Women frequently discussed the use of drugs and
concoctions to raise the CD4 count to avoid initiating
lifetime therapy.
The father of my baby said we can wait a little and
use bio-plus (a popular tonic in Southern Africa) to
Table 3 Demographic characteristics for the participating nurses








General nurse 4 (13)
Nurse midwife 27 (87)
Current designation
Nurse midwife 6 (19)
Senior nurse 4 (13)
“Sister” 2 (6)
Staff nurse 19 (61)





Table 4 Nurse designations
Nurse designation (lowest to highest
ranking position)
Role of nurse
Nursing Assistant This level nurse as depicted by the title assists the higher level nurses. They have very limited duties such
as providing childhood immunization; dispensary and they are not allowed to prescribe.
State registered Nurse (Staff nurse/General nurse) This level nurse does everything the midwives do except that they do not conduct ANC,
maternity/delivery services.
Nurse midwife This level nurse performs ANC services, delivery, post-natal care, and other services related to
maternal child health and curative services. They are usually the nurse-in-charge/senior nurse
of the facility when there are no doctors present.
Senior nurse This is more of the role than qualification. This person is usually the most senior midwife at the
facility where there are multiple individuals with the same qualification In most cases, this person
is the nurse-in charge and also oversee the day-to-day running of the facility just like the nurse-in
charge or in the absence of a nurse-in charge.
Nurse-in charge (Sister) This is the person in charge of the local health facility. They oversee the day-to-day running of
the facility just like the senior nurse.
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boost CD4 instead of taking the medication
spontaneously because the medication is lifetime
bidding (Woman).
Some women were not ready to make a lifetime com-
mitment to ART. Nurses discussed some women throwing
away the medication or delaying initiation after leaving
the facility until they felt ready.
I once heard that some women hide the pills when
they reach home and with the hope that one day they
will have the motivation to start taking them. It is said
that they plan to keep them hidden for quite some
time because they are told that once you start taking
them it should be a lifetime commitment (Nurse).
One of the concerns of lifelong ART was a fear of fail-
ure to adhere to ART and of developing resistance. The
women also expressed concerns about potential stock-
outs at the facility limiting their access to ART and
thereby putting them at risk for developing resistance.
(Women say) I don’t see myself being able to take
the medication for the rest of my life because I
don’t trust myself I will be able to follow all your
instructions (Nurse).
To help patients accept the lifelong commitment of
ART, one nurse discussed comparing HIV to other chronic
diseases that require lifelong medication.
…what I usually tell them is that HIV is not the only
illness where you have to take chronic medication.
Think about diabetes, hypertension, epilepsy, asthma,
heart disease and other stuff, so it’s the same with
HIV! (Nurse).
More information needed on ART
The most frequently cited challenges regarding the need
for more information about ART included: fear of side
effects, the number of clinic appointments before initiat-
ing ART, needing more information about HIV and ART
at the community level, and educating men about HIV
and ART.
Fear of side effects
One of the barriers most frequently raised by women
was fear of side effects caused by ART. The main side ef-
fects mentioned by women were: bursting liver, deformed
body, shrinking buttocks, body rashes, developing humps,
and looking like a man.
I once had a patient who was adamant that she didn’t
want to enroll on ART because she didn’t want to be
deformed and be like ‘a man’… She also gave me an
example of some people that she knows who have
those side effects. She said some of those people were
once pretty but now they are a far cry from their
former self” (Nurse).
Nurses believed that the side effects linked to deform-
ity were most likely associated with stavudine, an ARV
that is no longer in use. Throughout the FGDs both the
women and nurses raised the topic that there needs to
be more information about ART provided to women,
specifically on the topic of side effects.
Number of clinic appointments before initiating lifelong ART
Some women and nurses felt that fewer appointments
before initiating ART would decrease loss to follow-up,
avoid expensive transportation costs and save time.
Others felt that it was incredibly important to have mul-
tiple counseling appointments prior to ART initiation and
have time to absorb their HIV-positive diagnosis before
starting ART.
Some women feel there are too many (adherence
appointments). But women are different. Adherence
counselling is very important (Nurse).
Some nurses suggested flexibility regarding the num-
ber of pre-ART initiation appointments and allowing
nurses the discretion to determine how many appoint-
ments each woman needs.
One of the few issues that we have to take seriously
because if we prescribe two sessions for all adherences,
we are risking downfall in terms of technical outcomes…
while we fast track pregnant, positive women but also
try to evaluate individuals; really is this person really
going to be adherent? Do we still need more counselling
sessions or not? The appointment date; let’s make it
maybe closer, let’s not give one month supply. Let’s give it
two weeks supply and have another adherence
session in two weeks’ time. So I think it is
important that we do individual evaluations and
let’s not say two sessions and that’s it (Nurse).
More information needed at the community level
Nurses discussed the need for additional information
about HIV and ART to be shared at the community level.
Some reported that additional community education
could help decrease stigma.
People do not know the importance of [HIV] testing and
knowing your status. The people do not know, so they
are not motivated to request that service. We have to
do community mobilisation and health talks on HTC,
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and teach people and be ready to inform them about
the current statistics. We need to tell people how HIV
is linked to some of the illnesses currently prevailing
in Swaziland. Therefore, from that stand point,
everyone has to have information about HIV and be
encouraged to test so that stigma can be curbed
(Nurse).
Nurses discussed being too busy at the facility to be
able to provide health education at the community level.
Back in the day nursing was not just limited to curative
services and because of that we have the current disease
burden because people are not educated. Back then
as a nurse, you had to go to every community
meeting to give a lesson on health. But because we
now focus on curative interventions we are having
these challenges (Nurse).
Educating men about HIV and ART
Both nurses and women discussed the need for more ef-
forts to engage and educate men. FGD discussions
highlighted men’s fear of HIV and ART. When women
visit the health facility for ANC appointments they are
educated about HIV and ART, but the men do not have
the same opportunity. Men’s lack of knowledge creates
challenges for women. Women described informing
male partners of their HIV-positive status, asking their
partners to test and male partners becoming angry and
sometimes violent.
When I tried to convey the message of initiating ART
he just became impossible. Even if I give him the card
meant for our partners to come to the facility, he just
acts wildly and threatens to punch me. When I told
him I have since tested and I knew my status he just
said keep that to you. I will know mine when my time
has come. As for now I’m not even interested in
knowing yours (Woman).
Nurses and women discussed how men’s attitude toward
HIV and ART discourages their female partners from test-
ing and initiating ART. They may try to talk them out of
initiating ART or confuse them with false information.
Most often you find that men are misinformed about
issues and end up confusing women who are about to
start ART. So as part of improving our system we have
to find a way to engage men (Nurse).
The suggestions often included going to places that
men frequent regularly, such as community meetings,
churches and dip tanks and providing educational
messages about HIV and ART.
I’ll talk about something I came across in my own
community. There were some improvements last year.
There is an increase in male involvement. (PSI organized
a “Know Your HIV Status” Campaign targeted at men
who brought their cattle to the dip tanks). So, the men
would come and say, “I was at the dip tank and we got
tested,”… and those men are different since they know
their status… We still have some of them who come and
retest. This shows that they really got the message about
testing during the campaign (at the dip tank). So I think
we have to involve communities (Nurse).
Discussion
These results identify challenges and barriers faced by
pregnant and postpartum women when deciding to initi-
ate ART under Option A, where only women with more
advanced disease had ART recommended to them. Op-
tion B+ also requires a lifelong commitment to ART,
therefore understanding the barriers women experienced
under Option A can help to strengthen the acceptability
of Option B+. These findings highlight the challenges of
accepting lifelong ART and the need for more counsel-
ing during ART initiation.
Challenges accepting lifelong ART
Many factors contribute to the challenge of accepting and
initiating lifelong ART, including: the fear of developing
resistance; disclosing one’s HIV status or dealing with a
lifetime of hiding medications, and accepting and ac-
knowledging one’s HIV status daily by taking
medication.
Both women and nurses discussed the challenge of
pregnant women initiating ART when they feel healthy
despite having a low CD4 cell count. Under Option B+,
the requirement for a woman to have a low CD4 count
or advanced disease symptoms is removed and the
short-course prophylaxis option is no longer available;
therefore, more women who feel healthy will be offered
ART. During the piloting of Option B+ in Swaziland,
ART initiation rates were significantly lower among
women with a high CD4 count: 59 % of women with
CD4>350 initiated ART before 32 weeks gestation, com-
pared with 80 % of women with CD4<350 [15].
Women who may have known their HIV status previ-
ously or anticipated that they may be HIV-positive may
require fewer counseling sessions prior to initiating
ART, while those struggling to accept their new HIV sta-
tus and need to initiate ART may require more sessions.
These women may need time to accept their HIV status,
to disclose to a partner or family and be emotionally
prepared to commit to lifelong ART. A study in
Swaziland found that those who knew their HIV status
before attending ANC were more likely to begin ART
compared with those who were newly diagnosed during
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their ANC visit [15]. Research has also shown that loss
to follow-up (LTFU) is greatest in the first 3 months
after women are given ART under Option B+ when
using the same day initiation approach [16]. Providing
the opportunity for women to receive additional coun-
seling sessions before initiating ART, especially among
those newly diagnosed as HIV-positive, may reduce
LTFU. In addition, a study on Option B+ in Malawi
found that facilities that offered additional adherence
counseling beyond the required national guidelines had
lower rates of early LTFU [16]. Some women may re-
quire additional counseling due to personal circum-
stances such as an unanticipated HIV diagnosis, having
a support structure which allows for disclosure and be-
ing knowledgeable about HIV and ART. Previous re-
search has stressed the importance of understanding the
variability in personal circumstances when it comes to
counseling regarding ART and adherence [17]. Nurses
in this study advocated for the ability to decide how
many counseling appointments women need on an
individual basis. This is an important factor to con-
sider with Swaziland’s continued roll-out of Option B
+.
Fear of developing ART resistance is a commonly cited
barrier to treatment [18]. Study participants were aware
that good adherence was necessary to avoid developing
resistance. This awareness, however, also presented as a
barrier for initiating ART, as some patients delayed initi-
ation until they felt “ready to adhere for life.” In addition
to the fear of not being able to be adherent and develop-
ing resistance, some participants believed that if they
stopped taking ART at any point they would die. This
concern has also been documented in other studies [19].
To help patients accept lifelong medication, some of
the nurses discussed comparing HIV/AIDS to other
chronic diseases which require lifelong medication,
such as diabetes. They believed that these kinds of com-
parisons helped women to accept lifelong medication
easier by not seeming so “different” from others. This ap-
proach could help mitigate the fear some patients have
that being HIV-positive makes them different from other
people [20].
Requesting the short-course prophylaxis was one way
women attempted to avoid the commitment to lifelong
ART and still provide protection to their unborn child.
Strengthening the counseling messages to ensure that
women understand how lifelong ART also benefits their
health and partner’s health in addition to their child’s
health is important [21]. The new messaging around Op-
tion B+ will be critical, as the previous messaging stated
that ART is only for those with a CD4 count greater
than 350 [15].
To avoid initiating lifelong ART, study participants dis-
cussed using drugs, herbs, and concoctions to raise the
CD4 count above 350. Other studies have also cited the
use of herbs and plants to raise CD4 counts [20]. These
findings illuminate the lengths that some individuals
are willing to go to avoid initiating ART. These fears
and concerns about ART will continue unless they are
dealt with directly through improved counseling and
messaging.
More information about ART
The results of this study highlight a clear need for shar-
ing more information about ART, including its benefits
and side effects, for the general population and for
women at health facilities. The challenge of side effects
has been frequently discussed in the literature [18, 22]
and was also documented in this study. The descriptions
of side effects in the reviewed literature focus on dis-
comfort, such as headache, diarrhea, weight gain, dizzi-
ness, nightmares, nausea, pain and fatigue [18] while the
side effects discussed in our study focus on changing
physical features and deformities; study participants
often mentioned “becoming ugly, looking like a man,
losing the shape of one’s behind,” etc. Fear of treatment-
induced body changes has also been discussed in a quali-
tative study from Zambia [20]. Nurses explained that
such side effects are associated with ART and demon-
strate the fear of undesired disclosure and potential
stigma [23]. The nurses in this study mentioned that the
side effects associated with disfiguration were often the
result of stavudine, an ARV drug that is no longer in
use. However, the discontinuation of this drug has not
been discussed with the women or community at large.
Information about the new drugs being used with fewer
side effects under Option B+ needs to be communicated
to the public.
Other research has cited the need for providing more
information about PMTCT to the general public [24].
During the FGDs, nurses discussed that due to time con-
straints, they were often unable to spend adequate time in
the community providing health education. However, the
nurses acknowledged information and education needs to
be shared beyond women receiving services at the facility.
Study participants often discussed the need for im-
proved messaging targeting men. Previous research
has stated that men lack the opportunity to be taught
about HIV/AIDS and ART, as women may utilize
health facilities more than men because of pregnancy
[19]. In this study, both the women and nurses dis-
cussed Swazi men lacking information and education
about HIV.
Nurses recommended engaging men by providing HIV
testing at locations that men frequent. A review of male
involvement initiatives in PMTCT provided a few rec-
ommendations including restructuring maternal health
clinics so that they are culturally and practically acceptable
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to men, changing social and behavioral norms through
use of peer programs and community leaders and adding
outreach programs such as providing HIV testing at
home, personal invitations and other approaches, but
results are very mixed across country settings [25].
Study participants also discussed that Swazi men have
strong fears about HIV testing and claimed that some
men even discourage their partners from receiving ANC
services [26], as some men assume that their partner’s
positive status is an indication of their own HIV status
[27, 28]. One study noted that some women experienced
direct discouragement from their partner and that
women who did not live with their boyfriends had more
support to join a PMTCT program [24] which could
perhaps be attributed to stigma and fear of ARVs being
seen in the house. In a study in Lesotho some nurses
claimed that fear of disclosing to the partner is the main
obstacle, as the men will then blame the woman for
bringing HIV into the house [29].
With Option B+ significantly increasing the number of
women that will begin lifelong ART, it will become even
more important to engage the community, especially
men about the importance of lifelong ART to ensure
women receive support to initiate and adhere to ART.
The nurses recommend that men receive information
about HIV and ART at the locations they frequent such
as “dip tanks”, churches and community meetings. Other
organizations in Swaziland are currently informing and
educating men about HIV at their workplaces (especially
in the urban areas). However, more information is
needed about where is the best place to provide educa-
tional messages to men, who would be the best persons
to provide these education messages to men, which mes-
sages are most effective with men and where is the best
place for men to receive HIV tests.
Strengths and limitations
One of the strengths of this study was the use of two
data collection methods (interviews and FGDs) to
understand both the individual experience and the gen-
eral perspective of pregnant women and nurses. One
limitation was interviews being conducted by nurse mid-
wives who may have been involved in the care of study
participants. Another limitation was having only one
FGD with women who did not initiate ART; this was a
result of challenges recruiting this population.
Conclusion
As Option B+ continues to be rolled-out across Swaziland,
an increasing number of women who may be asymptom-
atic and feeling “healthy” will be asked to initiate lifelong
ART. Both women and nurses discussed major concerns
about the commitment of lifelong ART. The findings
highlight the need for strengthened messaging about the
benefits of lifelong ART, specifically to the mother and her
partner.
In addition, there is an increased need for information
sharing with the community about the current drugs be-
ing used in ART, and specifically informing the public
that the drug which caused lipodystrophy deformities is
no longer in use. As patients tend to have many ques-
tions regarding drug side effects, nurses and other health
staff should discuss the side effects promptly with the
patients to alleviate their inaccurate perceptions.
One method proposed by the nurses to decrease LTFU
is allowing increased flexibility for nurses to determine the
number of adherence counseling sessions a specific woman
receives. Creating a flexible system in which nurses can
identify those who need additional counseling could enable
nurses to keep women at higher risk of LTFU within the
system. Implementing and improving systems that follow
mother-baby pairs through the risk period for MTCT and
tracking those who do not return to the facility has become
increasingly important under Option B+ [30].
To address the information gap among men about
HIV and ART, study participants cited the importance of
targeted messaging and knowledge improvement, par-
ticularly around disclosure and status. As HIV and ART
are still stigmatized topics, women are less likely to dis-
cuss them with their partners. It is well documented in
the literature that disclosure is a significant challenge
and directly affects adherence. Finding ways of accessing
and educating men in the community about HIV and
ART will be critical for Option B+ to be effective.
The findings from this study highlight the challenges
that women have accepting lifelong ART. Previous re-
search has explored barriers initiating PMTCT and ART
but little research has sought to understand the concerns
associated directly with ART being a lifelong commit-
ment. Understanding what women are concerned about
will aid in developing effective counseling messages, de-
signing appropriate counseling structures, understanding
where additional support is needed, and knowing where
to target community level messages.
Endnote
1Commonly used in Swaziland to describe short-course
prophylaxis given during Option A.
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